Featured Research

from universities, journals, and other organizations

Fatherhood Linked To Prostate Cancer Risk

Date:
January 9, 2008
Source:
Wiley-Blackwell
Summary:
A new study from Danish researchers has found that childless men have a lower risk of developing prostate cancer than fathers, and that, paradoxically, the more children a father has, the lower the risk of the disease.

Childless men have a lower risk of developing prostate cancer than fathers, and paradoxically, the more children a father has, the lower the risk of the disease.
Credit: iStockphoto/Ann Marie Kurtz

A new study from Danish researchers has found that childless men have a lower risk of developing prostate cancer than fathers, and that, paradoxically, the more children a father has, the lower the risk of the disease.

Whether fatherhood can affect the risk of prostate cancer remains controversial. Evidence has suggested that childless men may be at lower risk of prostate cancer than men with children, and that men who father sons may be at lower risk than men with daughters only. To address the issue, researchers led by Kristian Jψrgensen of the Statens Serum Institut, in Copenhagen, Denmark, used a national population-based register to analyze data from all men born in Denmark between 1935 and 1988, among which 3,400 developed prostate cancer.

They found men without children were 16 percent less likely than those with children to be diagnosed with prostate cancer during up to 35-years of follow up. The analysis also revealed that among fathers, there was a gradually reduced prostate cancer risk with increasing number of children.

The authors suggest that, theoretically, this might reflect a "healthy father" phenomenon, in which men who retain fertility are less likely to develop a malignancy. The study found no association between prostate risk and child gender.

The analysis did not reveal what factors associated with childlessness might be responsible for the risk reduction. Currently known risk factors for prostate cancer are race, family history of prostate cancer, and advanced age. "Regardless of the underlying mechanism, the results of the current study provide prospective, epidemiologic support for the view that childless men are somehow at lower risk of developing prostate cancer," the authors wrote.

The authors also note that "additional studies are required to identify the underlying biologic, environmental, social and/or behavioral factors that explain the observed differences in prostate cancer risk between fathers and childless men and between men fathering few and those fathering many children."

Journal Article: "Fatherhood Status and Prostate Cancer Risk" Kristian T. Jψrgensen, Bo V. Pedersen, Christoffer Johansen, and Morten Frisch. Cancer; Published Online: January 7, 2008 (DOI: 10.1002/cncr.23230); Print Issue Date: February 15, 2008.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Fatherhood Linked To Prostate Cancer Risk." ScienceDaily. ScienceDaily, 9 January 2008. <www.sciencedaily.com/releases/2008/01/080107091027.htm>.
Wiley-Blackwell. (2008, January 9). Fatherhood Linked To Prostate Cancer Risk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/01/080107091027.htm
Wiley-Blackwell. "Fatherhood Linked To Prostate Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/2008/01/080107091027.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins